News & Articles

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

Download this white paper from Sartorius to discover how enhanced data analytics and translational models can provide new biological insights

The company aims to ramp up its production capacity of more than 50 million antibody tests per month

Test will be available at NHS laboratories across the UK, using its ARCHITECT i1000SR and i2000SR and Alinity i laboratory instruments

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research

Assay will help guide treatment decisions in cases of non-small cell lung cancer

The company says it continues to optimize its coronavirus test amid questions about its accuracy

Collaboration with WuXi Diagnostics and Mayo Clinic on serology test will complement Thermo Fisher's widely adopted TaqPath COVID-19 molecular diagnostic test

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

The Alinity m molecular laboratory COVID-19 test instrument claims it can run up to 1,080 tests in 24 hours

The U.S. Food and Drug Administration has authorized the first coronavirus test using at-home collection of saliva samples

Partnership to broaden the availability of COVID-19 antibody testing with 100% specificity